Changes in the characteristics of patients prescribed selective cyclooxygenase 2 inhibitors after the 2004 withdrawal of rofecoxib
Author:
Publisher
Wiley
Subject
Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy
Reference14 articles.
1. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis;Bombardier;N Engl J Med,2000
2. Gastrointestinal toxicity with celecoxib versus nonsteroidal antiinflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial;Silverstein;JAMA,2000
3. European Medicines Agency. URL: http://www.emea. europa.eu/htms/human/press/cox2QA.htm.
4. Channeling and prevalence of cardiovascular contraindications in users of cyclooxygenase 2 selective nonsteroidal antiinflammatory drugs;Mosis;Arthritis Rheum,2006
5. National trends in cyclooxygenase-2 inhibitor use since market release;Dai;Arch Intern Med,2005
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Effect of Acupuncture on Chronic Pain with Depression: A Systematic Review;Evidence-Based Complementary and Alternative Medicine;2020-06-25
2. Managing Chronic Pain in the Elderly: An Overview of the Recent Therapeutic Advancements;Cureus;2018-09-13
3. Efficacy of ultra-micronized palmitoylethanolamide (um-PEA) in geriatric patients with chronic pain: study protocol for a series of N-of-1 randomized trials;Trials;2016-07-29
4. Towards understanding the de-adoption of low-value clinical practices: a scoping review;BMC Medicine;2015-10-06
5. Lombalgia inespecífica crônica: reabilitação;Revista da Associação Médica Brasileira;2013-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3